US Patent Issued to Fred Hutchinson Cancer Center on Oct. 14 for "Genomic safe harbors for genetic therapies in human stem cells and engineered nanoparticles to provide targeted genetic therapies" (Washington Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,442,021, issued on Oct. 14, was assigned to Fred Hutchinson Cancer Center (Seattle).

"Genomic safe harbors for genetic therapies in human stem cells and engineered nanoparticles to provide targeted genetic therapies" was invented by Jennifer E. Adair (Seattle) and Reza Shahbazi (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "Genomic safe harbors (GSH) for genetic therapies in human stem cells and engineered nanoparticles to provide targeted genetic therapies are described. The GSH and/or associated nanoparticles can be used to safely and efficiently treat a variety of genetic, infectious, and malignant diseases."

The patent was filed on Dec. 8,...